| 1 |
35129807 | Zinc supplementation ameliorates sorafenib-induced cognitive impairment through ROS/JNK signaling pathway. | 2022 Feb 7 |
1 |
| 2 |
33667419 | Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity. | 2021 Jun |
1 |
| 3 |
34332981 | Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. | 2021 Sep 1 |
4 |
| 4 |
34767735 | RABL2A-CCDC34 Axis Promotes Sorafenib Resistance in Hepatocellular Carcinoma. | 2021 Nov |
1 |
| 5 |
32636042 | Retraction notice to "Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway" [Biomed. Pharmacother. 110 (2019) 213-223]. | 2020 Sep |
1 |
| 6 |
30476722 | Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway. | 2019 Feb |
3 |
| 7 |
29864454 | RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma. | 2018 Sep 28 |
3 |
| 8 |
29928452 | Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation. | 2018 Jul |
2 |
| 9 |
30132846 | Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells. | 2018 Jan |
1 |
| 10 |
30187994 | Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression. | 2018 Dec |
1 |
| 11 |
30443188 | The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction. | 2018 |
1 |
| 12 |
30459526 | IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway. | 2018 |
5 |
| 13 |
28055301 | Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer. | 2017 Mar 4 |
1 |
| 14 |
28178378 | Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma. | 2017 Apr |
3 |
| 15 |
29033791 | Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity. | 2017 |
1 |
| 16 |
26629768 | Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways. | 2016 Mar |
2 |
| 17 |
26964667 | Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence. | 2016 Mar 11 |
1 |
| 18 |
25683251 | Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib. | 2015 May |
1 |
| 19 |
26460271 | Sorafenib inhibits cancer side population cells by targeting c‑Jun N‑terminal kinase signaling. | 2015 Dec |
4 |
| 20 |
26517516 | Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells. | 2015 Nov 17 |
1 |
| 21 |
24170769 | Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK. | 2014 Jan |
4 |
| 22 |
24402682 | ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells. | 2014 Mar |
1 |
| 23 |
24726537 | Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening. | 2014 Jul |
1 |
| 24 |
25245054 | Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. | 2014 Dec |
1 |
| 25 |
22596232 | Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma. | 2012 Jun 5 |
6 |
| 26 |
20301194 | Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways. | 2010 Jul |
3 |
| 27 |
21062976 | Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells. | 2010 Nov 15 |
4 |
| 28 |
16985072 | Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. | 2006 Sep |
2 |